Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA Inc (NASDAQ: XRAY) and Dynavax (NASDAQ: DVAX)

By Austin Angelo

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA Inc (NASDAQ: XRAY) and Dynavax (NASDAQ: DVAX) with bullish sentiments.

DENTSPLY SIRONA Inc (NASDAQ: XRAY)

Jefferies analyst Brandon Couillard reiterated a Buy rating on DENTSPLY SIRONA Inc (NASDAQ: XRAY) today and set a price target of $66. The company’s shares opened today at $50.19, close to its 52-week low of $48.25.

According to TipRanks.com, Couillard is a top 100 analyst with an average return of 27.1% and a 72.6% success rate. Couillard covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, Orasure Technologies, and Becton Dickinson.

DENTSPLY SIRONA Inc has an analyst consensus of Moderate Buy, with a price target consensus of $65.83.

Dynavax (NASDAQ: DVAX)

Cantor Fitzgerald analyst Elemer Piros reiterated a Buy rating on Dynavax (NASDAQ: DVAX) today and set a price target of $27. The company’s shares opened today at $18.85.

Piros observed:

“Dynavax provided Phase 1b/2 updates on TLR9 agonist, SD-101 in combination with Keytruda, for head and neck squamous cell carcinoma (HNSCC) and metastatic melanoma at AACR.”

According to TipRanks.com, Piros is ranked 0 out of 5 stars with an average return of -3.8% and a 47.1% success rate. Piros covers the Healthcare sector, focusing on stocks such as Spring Bank Pharmaceuticals Inc, Strongbridge Biopharma Plc, and Global Blood Therapeutics.

Dynavax has an analyst consensus of Strong Buy, with a price target consensus of $29.40.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.